Denali Therapeutics Inc (DNLI)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
3,259,289,000
EV to revenue ratio (TTM)
719.26
EV to ebitda
86.48
Financial Performance
Revenue (TTM)
3,604,000
Gross profit (TTM)
-397,208,992
EBITDA
-526,057,984
Profitability
Operating margin (TTM)
-3,601.00%
Profit margin
0.00%
Return on assets (TTM)
-29.10%
Return on equity (TTM)
-54.90%
Per Share Metrics
Revenue per share (TTM)
0.02
EPS
-2.84
Diluted EPS (TTM)
-2.84
Book value
5.23
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
904.35
Price to book ratio (TTM)
3.916
Growth
Quarterly earnings growth (YoY)
-100.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
2
Buy
17
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.005